Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Nanoco director linked to £1.7m share sale

(Sharecast News) - Quantum dots and nanomaterials producer Nanoco Group was at the top of the list of director sells on Wednesday, after a transaction worth over £1.7m was made, linked to a non-executive director. The London-listed firm said Lombard Odier Asset Management Europe sold five million shares on Monday.

It sold each share for 34.2p, netting it a total of £1,710,000.04 in the process.

Nanoco said the company is closely associated with its director Henry Turcan, who is the investment manager at Lombard Odier's 1798 Volantis operation.

Reporting by Josh White at

Top Director Buys

Reneuron Group (RENE) Director name: Staehelin,Barbara Amount purchased: 127,000 @ 30.32p Value: £38,502.46

Active Energy Group (AEG) Director name: Rowan ,Michael Amount purchased: 750,000 @ 4.10p Value: £30,750.00

Capital Gearing Trust (CGT) Director name: Matterson,Jean Amount purchased: 450 @ 4,981.50p Value: £22,416.75

Jpmorgan European Growth & Income (JEGI) Director name: Dhut,Rita Amount purchased: 26,000 @ 76.11p Value: £19,788.24

Alphawave Ip Group (AWE) Director name: Sutardja,Sehat Amount purchased: 10,000 @ 126.99p Value: £12,699.00

Coro Energy (CORO) Director name: Hood,Mark Amount purchased: 3,694,889 @ 0.27p Value: £10,124.00

React Group (REAT) Director name: Braund,Mark Amount purchased: 951,476 @ 1.05p Value: £9,990.50

Foresight Sustainable Forestry Company (FSF) Director name: Bush,Josephine Amount purchased: 9,000 @ 107.00p Value: £9,630.00

Active Energy Group (AEG) Director name: Rowan ,Michael Amount purchased: 150,000 @ 4.20p Value: £6,300.00

Getbusy (GETB) Director name: Haworth,Paul Amount purchased: 10,000 @ 58.08p Value: £5,808.00

Active Energy Group (AEG) Director name: Rowan ,Michael Amount purchased: 100,000 @ 4.00p Value: £4,000.00

Thorpe (f.w.) (TFW) Director name: Cooper,Anthony Amount purchased: 520 @ 376.50p Value: £1,957.80

Thorpe (f.w.) (TFW) Director name: Cooper,Anthony Amount purchased: 520 @ 376.50p Value: £1,957.80

Hipgnosis Songs Fund Limited Npv (SONG) Director name: Sutch,Andrew Amount purchased: 727 @ 109.15p Value: £793.50

Imi (IMI) Director name: Twite,Roy Amount purchased: 13 @ 1,195.44p Value: £155.41

Centrica (CNA) Director name: Ringrose ,Kate Amount purchased: 183 @ 81.99p Value: £150.04

Centrica (CNA) Director name: OÂ'Shea,Chris Amount purchased: 182 @ 81.99p Value: £149.22

Imi (IMI) Director name: Shook ,Daniel Amount purchased: 10 @ 1,195.44p Value: £119.54

Top Director Sells

Nanoco Group (NANO) Director name: Turcan,Henry Amount sold: 5,000,000 @ 34.20p Value: £1,710,000.04

Polar Capital Holdings (POLR) Director name: Rochussen,Gavin Amount sold: 65,351 @ 473.18p Value: £309,227.87

Polar Capital Holdings (POLR) Director name: Mansell,John Amount sold: 32,853 @ 473.18p Value: £155,453.83

Polar Capital Holdings (POLR) Director name: Ayub,Samir Amount sold: 1,884 @ 473.18p Value: £8,914.71

Share this article

Related Sharecast Articles

Director dealings: Blue Coast raises stake in Everyman Media
(Sharecast News) - Everyman Media revealed on Thursday that Blue Coast had acquired 50,000 ordinary shares in the AIM-listed cinema group.
Director dealings: Angus Energy CEO ups stake
(Sharecast News) - Angus Energy revealed on Wednesday that chief executive Richard Herbert had acquired 5.0m ordinary shares in the AIM-listed onshore oil and gas development firm.
Director dealings: Abrdn CEO makes share sale
(Sharecast News) - Abrdn revealed on Monday that chief executive Stephen Bird had disposed of 29,942 ordinary shares in the FTSE 250-listed global investment company.
Director dealings: Redx Pharma CEO ups stake
(Sharecast News) - Redx Pharma revealed on Friday that chief executive Lisa Anson had acquired 399,000 ordinary shares in the AIM-listed clinical-stage biopharmaceutical firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.